Cell Therapy Company Receives FDA Greenlight For SR-aGVHD Treatment

FDA Greenlights Mesoblast's Groundbreaking Treatment for Children with Severe Graft Versus Host Disease.

As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.